ario pharma has raised funds from the following international leading life sciences venture capital firms:

New Science Ventures, LLC (NSV) is a New York-based venture capital firm which invests in companies using novel scientific approaches in the Life Sciences sector and the Information Technology sector.

Forbion Capital Partners invest in Life Sciences and Biomedical Technology companies developing world-class drugs and technologies, with a clear focus on product development.

Seroba is an established European life sciences venture capital firm, focused on investing in breakthrough venture capital healthcare technologies that promise to improve lives and make a difference worldwide.